Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT01689558Phase 3Unknown
- Sponsor
- Jinfeng Medical
- Start
- Dec 2011
- Primary completion
- Jan 2015
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of endostar in nasopharyngeal carcinoma (NPC), sponsored by Jinfeng Medical. Status: unknown.
02
Drugs
endostar
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01689558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01689558.